Completed NA INTERVENTIONAL 1-arm NCT05448378

Evaluation of D-chiro-inositol Treatments

Evaluation of the Effects of D-chiro-inositol in Female Healthy Volunteer

Sponsor: Lo.Li.Pharma s.r.l

Conditions Asprosin Inositol Insulin Ovulation Testosterone

Updated 4 times since 2022 Last updated: Sep 16, 2022 Started: Jun 4, 2022 Primary completion: Aug 30, 2022 Completion: Sep 16, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Asprosin and Inositol and is currently completed. Lo.Li.Pharma s.r.l leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lo.Li.Pharma s.r.l

Data source: Lo.Li.Pharma s.r.l

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy